title: Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis.
abstract: OBJECTIVE
  To clarify the clinical features and prognosis of systemic sclerosis (SSc) based on serum antinuclear antibodies (ANA).
  
  
  METHODS
  We studied 275 consecutive Japanese patients newly diagnosed as having SSc, who were first evaluated during the period 1971-1990. Eight SSc-related ANA were identified using indirect immunofluorescence, double immunodiffusion, or immunoprecipitation assays. Clinical and prognostic features were retrospectively analyzed in patient groups, categorized by their serum ANA.
  
  
  RESULTS
  Cumulative survival rates at 10 years after diagnosis of SSc were 93% in patients with anticentromere antibodies (ACA), 72% in those with anti-U1 RNP, 66% in those with anti-DNA topoisomerase I (anti-topo I), and 30% in those with anti-RNA polymerases I, II, and III (anti-RNAP). Major organ involvement linked to cause of death included biliary cirrhosis in patients with ACA, isolated pulmonary arterial hypertension and cerebral hemorrhage in those with anti-U1 RNP, pulmonary interstitial fibrosis in those with anti-topo I, and cardiac and renal involvement in those with anti-RNAP.
  
  
  CONCLUSIONS
  Determinations of serum ANA in SSc patients are useful in predicting organ involvement and long-term outcome.
authors.affiliation: Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Kuwana
authors.forename: J
authors.initials: J
authors.lastname: Kaburaki
authors.forename: Y
authors.initials: Y
authors.lastname: Okano
authors.forename: T
authors.initials: T
authors.lastname: Tojo
authors.forename: M
authors.initials: M
authors.lastname: Homma
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000097:blood*; D002423:Cause of Death; D004264:DNA Topoisomerases, Type I / Q000276:immunology; D005260:Female; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D017412:Ribonucleoprotein, U1 Small Nuclear / Q000276:immunology; D012595:Scleroderma, Systemic / Q000097:blood* / Q000145:classification / Q000453:epidemiology*; D015996:Survival Rate
chemical_list: D000906:Antibodies; D000974:Antibodies, Antinuclear; D017412:Ribonucleoprotein, U1 Small Nuclear; D004264:DNA Topoisomerases, Type I